my country's total import value of pharmaceutical products increased by 14.9% in the first three quarters

Source: xinhua.com.cn on November 4, 2014, Tan Shengcai, Deputy Secretary General of China Chamber of Commerce for the import and export of medical and health products, said in an interview with Xinhua News Agency on November 3 that in the first three quarters of this year, China's total import value of medical products increased by 14.9% year-on-year, close to the expected annual growth of 15%, showing a positive trend In an interview with reporters at the 116th Canton Fair, Tan Shengcai said that with the promotion of domestic demand and policy factors, the import of China's pharmaceutical products has maintained a stable and rapid growth At the same time, the pace of China's pharmaceutical industry integrating into the international multilateral mutual recognition system is also accelerating According to the introduction, China's import of pharmaceutical products mainly focuses on high-end preparations, APIs, specialty drugs and high-end medical devices and diagnostic equipment, and the expansion of import to a certain extent also stimulates similar enterprises in China to achieve the improvement of product quality and technical level It is in this context that how Chinese enterprises face the international mutual recognition system represented by pics (drug inspection agreement and drug inspection cooperation plan) has become the focus of the global industry In this regard, Meng Dongping, vice president of China Medical Insurance chamber of Commerce, said that as a global pharmaceutical production and consumption country, China's pharmaceutical industry is open to this China's accession to the multilateral mutual recognition system of international medicine will meet the challenges as well as major opportunities "In our opinion, the unification of regulatory standards is conducive to the better" going out "of Chinese enterprises and products In the future, the situation of international competition will intensify It is not enough for enterprises to fight alone, or it depends on institutional and institutional arrangements and guarantees " Meng Dongping said